VPH-80238-16809
2 vaccinations
0 coded responses
10 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 024 / MA
- Registered
- 2021-11-10
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-11-10
Registered in v-safe
-
2021-11-10
Dose 2 — Pfizer-BioNTech
-
2021-11-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-11-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-11-14
- 2021-11-17
- 2021-12-01
- 2021-12-15
- 2021-12-22
- 2022-02-09
- 2022-05-13
- 2022-11-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | No |
| 2 | 2021-11-10 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.